Insights

Portfolio

Our investment in Foodsteps
B2B SoftwarePortfolio
24 May 2022

Our investment in Foodsteps

Octopus Ventures is backing Foodsteps as it builds a platform to help decarbonize the food supply chain
Written by Lucy Clarke
Our investment in Delio
B2B SoftwarePortfolio
9 Mar 2022

Our investment in Delio

Delio provides a digital platform for financial institutions and organisations to enhance their offering when connecting private deal flow with high net worth capital. Read why Octopus Ventures have led their latest funding round
Written by Edward Keelan
Our investment in Nosso
FintechPortfolio
8 Mar 2022

Our investment in Nosso

Read about Octopus Ventures investment in Nosso, the finance app for families and their children.
Written by Tosin Agbabiaka
Our investment in Automata
HealthPortfolio
1 Mar 2022

Our investment in Automata

Automata is helping scientists achieve better results faster with automated lab solutions. Read why Octopus Ventures have led their latest investment round
Written by Jess McCreadie
Our investment in Biofidelity
HealthPortfolio
1 Mar 2022

Our investment in Biofidelity

Octopus Ventures investment in Biofidelity. Understand the who and why behind our latest deal announcement
Written by Uzma Choudry
Our investment in HURR
ConsumerPortfolio
24 Feb 2022

Our investment in HURR

HURR aims to reinvent what ownership means for consumers by offering the first full-stack fashion rental solution. Find out why Octopus Ventures have invested in them.
Written by Matt Chandler
Mention me
B2B SoftwarePortfolio
17 Feb 2022

Mention me

Why we invested in Mention Me’s groundbreaking referral marketing technology
Written by Uthish Ranjan
Our investment in APLYiD
B2B SoftwarePortfolio
18 Nov 2021

Our investment in APLYiD

Find out why we backed APLYiD, a reg-tech startup building a scalable solution to AML and KYC processes.
Written by Edward Keelan
Our investment in Tuune
HealthPortfolio
1 Nov 2021

Our investment in Tuune

Millions of women struggle with side effects related to contraception, here’s how Tuune will solve it
Written by Uzma Choudry
Our Investment in Imophoron
HealthPortfolio
20 Oct 2021

Our Investment in Imophoron

Imophoron is aiming to revolutionise the vaccine industry with its disruptive new technology.
Written by Uzma Choudry
Our investment in Turtl
B2B SoftwarePortfolio
19 Oct 2021

Our investment in Turtl

Turtl, our latest investment, is streamlining content marketing and boosting engagement.
Written by Uthish Ranjan